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A B S T R A C T
Purpose: It is accepted that the estrodiol hormone is proconvulsant and progesterone is anti-convulsant.
In this study the effects of gonadal hormones on photoparoxysmal responses on EEG in idiopathic
generalised epilepsy were researched.
Method: Twenty-two women with photosensitive idiopathic generalised epilepsy having regular
menstrual cycles were recruited into the study. Patients presenting photoparoxysmal responses were
selected from routine EEG recordings. Blood samples were taken on day 14 (E) and 25 (P) of the
menstrual cycle to conﬁrm E and P peaks. An EEG recording was performed for each patient on E and P
days.
Result: No statistically signiﬁcant differences were monitored with respect to frequency, duration of the
photoparoxysmal responses on E and P peaks days (p > 0.05).
Comment: In this study no correlation could be demonstrated among menstrual cycle and
photoparoxysmal responses.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Seizures do not occur randomly, rather they cluster around
certain periods of menstrual cycle in female patients and this
pattern is deﬁned as catamenial epilepsy.1 Heading from these
observations many researches have inquired the effect of gonadal
hormones on epileptic seizures. Consequently, it is indicated that
the estrogen hormone acts as proconvulsant and progesterone as
anti-convulsant.2 But on experimental studies it is pointed out that
especially the proconvulsant effects of estrodiol cannot be shown
consistently in all studies.3
The most frequent reﬂex precipitant for epileptic seizures is the
photic stimulation. Even if there is no clinical manifestation, some
patients usually in idiopathic generalised epilepsy (IGE) group,
exhibit paroxysmal photoconvulsive responses (PPRs) (spike and
wave, multiple spike and wave activities) during intermittent
photic stimulation (IPS).4 Despite that catamenial epilepsy is often
observed in focal epilepsies, it is known that menstrual period may
trigger seizures in photosensitive and IGE patients, also.4 In a study
where the excitability of motor cortex is evaluated in a group of 6
patients with catamenial epilepsy including one IGE, it is observed
that cortical silent periods shorten during menstruation and is
explained with decreased GABAergic inhibiton.5* Corresponding author. Tel.: +90 212 414 30 00.
E-mail address: snaz@istanbul.edu.tr (S.N. Yeni).
1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.04.014Another remarkable feature is that the photosensitivity is more
often observed in women.4 The contribution of gonadal hormones
on this tendency is not known. To our knowledge, there is not any
study in the literature regarding the role of menstrual cycle on
PPRs. Thus, in this study the effect of menstrual cycle thus of the
gonadal hormones on PPRs is evaluated.
Our statement is that if the estrogen is a proconvulsant
hormone, it can have an increasing effect on PPRs or vice versa.
2. Method
Female patients presenting PPRs during routine EEG recordings
in our EEG laboratory and who had regular menstrual cycle story
(28  1 days) were included in the study. Any degree of PPRs
according to Waltz et al. criteria were allowed for inclusion to the
study. Spontaneous discharges on baseline EEG were not used as a
criteria for exclusion or inclusion. No catamenial pattern was
reported in this sample. Progressive myoclonic epilepsies were
excluded. There was no consideration with regards to time interval
between baseline EEG and the ﬁrst study EEG. Certain drugs and
changes in drug regime at baseline EEG and during study period was
not regarded as an exclusion criteria.
Blood samples were taken on day 14 (E) and 25 ( 1) (P) of the
menstrual cycle to conﬁrm E and P peaks (95–433 pg/ml interval was
accepted to be sufﬁcient for estrogen peak, 5.1–18.5 ng/ml interval
for progesterone).2,6,7vier Ltd. All rights reserved.
Fig. 1. A photoparoxysmal response of patient 20 during estrogen phase (HF: 70 Hz, TC: 0.3 sn, sensitivity 7 mV).
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Kohden device and LS-901A photic stimulator was used for
recordings. The stroboscope stimulating white light was rectan-
gular. Electrodes were placed according to 10–20 electrode
montage system. IPS protocol was designed as 1, 3, 6, 9, 12, 15,
18, 21, 24, 27, 30, 33, 50, 60 and then 60, 50, 33, 30, 27, 24, 21, 18,
15, 12, 9, 6, 3, 1. Each stimulus period was carried out 10 s, eyes
open for the ﬁrst 5 s and then with eyes shut(in between interval is
10 s). The source of the stimulus was held at 30 cm far to the nasion
of patient. The intensity of stimulus was set as 0.64 J, and its
luminance value was set as 4 lx. Stimulation was presented in a
dim room light.4,8–10 Patients attended the examination after a full
night sleep and full. Antiepileptic drugs were not stopped. Changes
in drugs and their dosage were allowed during the study period.
EEG recordings were evaluated by two independent neurolo-
gists (1st and 2nd authors). No consensus was composed in three
patients and after evaluation by a third neurologist, a consensus
was established (4th author).
Spike and wave, multiple spike and wave discharges spontane-
ously and also during IPS were evaluated. They were compared
with respect to changes on days E and P. Parameters for
comparison of photoparoxysmal responses were frequency ofFig. 2. A grade I photoparoxysmal response of patient 4 during discharges, frequency bands at which they were monitored,
duration of the PPRs, absence–presence of the discharge according
to open–closed eyes state and continuation of discharge after the
termination of the stimulus and presence of spontaneous
discharges (Figs. 1 and 2). On the evaluation of photoparoxysmal
responses, the classiﬁcation of Waltz et al. was used and any
degree of PPRs were included in comparisons.11
For statistical analysis NCSS (number cruncher statistical
system) 2007&PASS 2008 Statistical Software (Utah, USA) program
was used. For the comparison of quantitative data Wilcoxon sign
test was used. Chi-square test and Mc Nemar tests are used on the
comparison of qualitative data. Relevance was evaluated at
p < 0.05 level.
3. Results
Twenty-two female patients were included in the study. The
average age of patients was 24.73  8.48 years. All of the cases were
classiﬁed as having idiopathic generalised epilepsy (4 isolated
generalised tonic clonic attacks, 4 absence syndromes, 1 photosensi-
tive epilepsy, 13 juvenile myoclonic epilepsy). The average epilepsy
duration was 9.8 years. Eighteen cases were receiving Na Valproateprogesteron phase (HF: 70 Hz, TC: 0.3 sn, sensitivity 7 mV).
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treatment, one case carbamazepine treatment, and two patients did
not receive treatment at the beginning of the study (during baseline
EEG), valproate 500 mg/day was started during the study period.
Eleven patients were in remission, 7 patients had seizure recurrence
due to low dose, incompliance, utilization of carbamazepine. The
response to treatment was insufﬁcient in monotheraphy in two
patients, lamotrigine was added-on in these patients as to be titrated.
PPRs were monitored in 16 of 22 patients on day E and in 14 of
them on day P. In two patients PPRs were observed on day E only
and in one patient on day P only. There were no statistical
difference with respect to above parameters on PPRs on days E and
P (p < 0.05) (Table 1). In a group of ﬁve patients no PPRs were
observed on both days. The mean age of this group was 23.05 and
there was no statistical difference between the ages of discharge
positive group (p = 0.204) (mean age of PPRs positive patients: 21).
The correlation of number and duration of PPRs as with regard to
age revealed no signiﬁcance (Table 2).
4. Discussion
In this study the effects of estrodiol and progesterone hormones
on PPRs were reviewed in female patients and no statistical
differences were found.
As the patients were in variable phases of cycle during baseline
EEG, this EEG was not included in comparisons. It seems that an
additional recording during the menses would be contributory.
In none of the cases, ovulation follow-up was performed with
ultrasonography and serial hormone levels could not be moni-
tored. Even if the estrogen, progesterone levels were in expected
ranges, the deﬁned interval was notably wide and it was not
possible to make a comment on the existence of ovulatory cycles of
the patients and whether being at full peak periods on days of EEG
recordings.
Not all the patients exhibited PPRs on the study EEG recordings.
Incompliance to treatment and seizure recurrences before baseline
EEG and changes in drugs during study period may account to this
discrepancy.
Two patterns were reported for ovulatory cycles in catamenial
epilepsy.2 Seizures increase around menses and during days
coinciding ovulation under the inﬂuence of gonadal hormones.Table 1
Comparison of number and duration of photoparoxysmal responses (PPRs) during
intermittent photic stimulation (IPS) and comparison of spontaneous discharges
(number of patients with PPRs during ostrogen phase is 16, during progesteron
period is 14).
Estrogen Progesteron Z p
Duration of PPRs (s) 11.12  14.5 8.63  9.33 1.15 0.248
Total number of PPRs 5.13  5.03 5.44  4.72 0.98 0.326
Number of spontaneous
discharges
1.64  3.19 1.91  6.36 0.54 0.587
Table 2
Correlation of PPRs on estrogen and progesterone days with regard to age. r,
correlation ratio.
Age
Duration of PPRs, Estrogen r 0.240
p 0.353
Duration of PPRs, Progesteron r 0.058
p 0.836
Total number of PPRs, Estrogen r 0.079
p 0.763
Total number of PPRs, Progesteron r 0.065
p 0.804There are various ways how sex hormones affect seizures.
Steroids act in the brain by direct membrane mediated effects
and receptor mediated effects (short latency and long latency,
respectively).12 Estrodiol increases the glutamate response of
neurons. Furthermore it is also effective on membrane
excitability through binding to GABA-A receptor and by
cytosolic neuronal estrogen receptor-mediated mechanisms.
These receptors are particularly abundant in the temporo-limbic
system, therefore explaining the higher frequency of catamenial
seizures in temporal lobe epilepsies.12 Long latency effects cause
structural and functional changes at excitatory synapses.13,14
Genomic effect of estrogen is through affecting mRNA, changes
the synthesis speed of GABA, coding the GABA amino
decarboxylase (GAD) enzyme and decreasing the synthesis of
GABA receptor subunits (12, 14).
Progesterone increases the entrance of chloride ions inside the
cell through GABAergic ways. Furthermore it is proposed that
progesterone decreases excitatory glutamatergic effects in the
temporal lobe. It also increases GABA synthesis and the number of
GABA-A receptor subunits genomically.2,12–15
Frontorolandic and occipital cortex seem to be the most
involved areas in generating PPRs.16 There is ample evidence that
PPRs is genetically determined.16,17 GABAergic mechanisms may
play an important role in the pathophysiology of photosensitivity,
and that GABAergic agonists may suppress PPRs.16 Animal models
suggest that many other neurotransmitters have a role in the
generation of photosensitivity in idiopathic generalised epilepsies
(serotonin, glutamate, neuropeptide Y, channel blokers such as
Ca2+-channel, K+-channel, Na+-channel, Na–H exchanger, gluta-
mate transporter).16,17 As hormones, via neurotransmitters such as
GABA, play a role on seizure recurrences, and that photosensitivity
is suppressed by GABA agonists, we may expect to ﬁnd some
changes on PPRs with changing hormonal levels. However, in this
study the effect of gonadal hormones on photoparoxysmal
responses in cases with IGE cannot be demonstrated. Methodo-
logical issues discussed above may account lack of signiﬁcance.
Another explanation is that gonadal hormones have negligible
effects on PPRs of IGE patients. In experimental models, estrogen
acts as proconvulsant on focal seizures particularly in some brain
areas. Clinically, catamenial epilepsy is observed more often in
temporal lobe epilepsies compared to extratemporal lobe epilep-
sies, in left sided temporal lobe epilepsies compared to right
sided.18,19 Other factors such as aging can also change the effects of
gonadal hormones. Catamenial pattern becomes more evident by
the increasing age in patients with temporal lobe epilepsy.
Independent from the cyclic effects of hypothalamopituitary axis,
it is claimed that age is effective in modulation.19 Gonadal
hormones have modulating effects on receptors and these effects
can be completely variable in different periods of cycle. Various
studies indicate that there are factors other than estrogen levels
determining the sensitivity of seizures to estrogen.3 It is observed
that estrogen shortens latent period in kainic acid seizures, but that
it does not make this effect on ﬂurothyl-induced seizures.20 In
another study it is indicated that even if estrogen has effects in
kainic acid induced seizures, it does not have an effect on status
epilepticus.20 Also there are some studies suggesting a possible
protecting effect of estrodiol on experimental models.21 On the
other hand, studies regarding the anticonvulsant effects of
progesterone indicate more consistent results.3 It is demonstrated
that progesterone administration decreases spike activity on EEG
in focal epilepsies.22 By the aforementioned information it is
possible to say that proconvulsant effects of estrogen hormone is
variable depending on the type of the experimental model, the
seizure, syndrome, localization, lateralisation of seizures, age,
genetic features of the individual. Thus, this variability may be
used to explain our model, that gonadal hormones have no effect
B. O¨ztu¨rk et al. / Seizure 20 (2011) 598–601 601on PPRs in female IGE patients. We need further studies to answer
this hypothesis.
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